Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage
#2PRI RANKED
Most Cited Paper
in Atrial Fibrillation Management and Outcomes
18 Months Post-Publication
Class of 2026
“Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
andexanet alfa · factor Xa inhibitors · Intracranial hemorrhage · hematoma expansion · hemostatic efficacy · Anti-factor Xa activity · prothrombin complex concentrate · atrial fibrillation · National Institutes of Health Stroke Scale · Thromboembolism · Ischemic stroke · modified Rankin scale · hematoma volume · rescue therapy · anticoagulation reversal
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers, Class of 2026. https://pri.pepkio.com/top-papers/atrial-fibrillation-management-and-outcomes/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459